
Vensana Capital is a venture capital and growth equity investment firm dedicated to partnering with entrepreneurs who seek to transform healthcare through breakthrough innovations in medical technology. The firm invests in development- and commercial-stage medtech companies, with offices in Minneapolis, MN and McLean, VA.
50% of their portfolio is in Healthcare. Deal activity decreased year-over-year (1 deals in the last 12 months vs 4 prior). Average disclosed round size is $46.7M (across 15 rounds with reported amounts).
Portfolio
17
Fund Size
$425M
Top Stage
Unknown
Last 12 Mo
1
Team
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
18 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| Series A | $30M | Jan 2026 | |
| Series D | $75M | Jun 2025 | |
| SSpyGlass Pharma, Inc | Series D | — | Jun 2025 |
| SSpyglass | Series D | — | Jun 2025 |
| Unknown | $32.5M | Oct 2024 | |
| Series G | $50M | Apr 2023 | |
| RRelievant Medsystems, Inc. | Series G | $50M | Apr 2023 |
| Series B | — | Jan 2023 | |
| NNyra Medical, Inc. | Series A | $20M | Nov 2022 |
| Series A | $21M | Dec 2021 | |
| CCleerly Coronary | Series B | $43M | Jun 2021 |
| Unknown | $70M | Oct 2020 | |
| Unknown | $50M | Jul 2020 | |
| PPGDx | Series C | $103M | — |
| AAlleviant Medical, Inc. | Unknown | $75M | — |
| VVesper Medical Inc | Unknown | $37M | — |
| LLuna Health | Series A | $23.6M | — |
| Series B | $20M | — |
Top Co-Investors
New Enterprise Associates9 shared
Gilde Healthcare6 shared
Lightstone Ventures4 shared
Sands Capital4 shared
Canaan Partners3 shared
Morgenthaler Ventures3 shared
Endeavour Vision3 shared
Vertex Ventures HC3 shared
Samsara BioCapital3 shared
Ally Bridge Group2 shared
RA Capital Management1 shared
Epidarex Capital1 shared
Broadview Ventures1 shared
U.S. Venture Partners1 shared
New Leaf Venture Partners1 shared
LRVHealth1 shared
The Cigna Group Ventures1 shared
DigiTx Partners1 shared
Longitude Capital1 shared
Boutique Venture Partners1 shared
Last updated: 9 September 2026